Roswell Park, Generate Biomedicines Launch Ovarian Cancer Trial
Generate Biomedicines Inc. and Roswell Park Comprehensive Cancer Center have launched an exclusive clinical trial for an 'armored' CAR T-cell therapy aimed at treating ovarian cancer.
Generate Biomedicines Inc. and Roswell Park Comprehensive Cancer Center have launched an exclusive clinical trial for an 'armored' CAR T-cell therapy aimed at treating ovarian cancer.